Christian Scott's Rough Triple-A Return Raises Questions After Tommy John Surgery

Christian Scott, one of the Mets' most promising pitching prospects according to Baseball America, surrendered 7 runs on 9 hits across 3.1 innings in his first Triple-A outing since Tommy John surgery, a rough return that tells the organization more about where his command and feel currently sit than about the ceiling that made him one of their most exciting young arms.

The 26-year-old right-hander, named the Mets' 2023 Minor League Pitcher of the Year after posting a 2.57 ERA and 107 strikeouts in 87.2 innings across three levels, was pulled from his Syracuse start in the fourth inning on 65 pitches, his first regular-season game action since July 21, 2024, a gap of nearly two years that any honest evaluation of the outing must account for.

Scott's hybrid elbow procedure, announced September 18, 2024 by agent Nate Heisler of Klutch Sports, combined a traditional Tommy John ligament replacement with a stabilizing internal brace performed by Dr. Keith Meister. The internal brace was designed to shorten the standard 12-to-18-month recovery window, yet Scott still missed the entire 2025 season. He entered 2026 spring training without physical limitations and opened Grapefruit League play encouragingly: 2.2 scoreless innings against Team Israel on February 11, striking out five. Across six total spring innings, though, his 4.50 ERA and 1.67 WHIP offered early warning that command refinement remained a work in progress.

Averaging roughly 19 pitches per inning, the 65-pitch outing signals that strike-to-ball consistency was a primary issue. Baseball America grades Scott's four-seam fastball at 92-94 mph, a pitch that plays well beyond its raw velocity thanks to approximately seven feet of extension off the mound, with an above-average split-change and slider rounding out the arsenal. That is a profile that should not produce 9 hits in 3.1 innings; the results suggest something was off in release point or location, if not both. The Mets will want to see whether the split-change is regaining its late depth and whether the fastball is holding its shape through counts over the next two to three starts, the benchmarks that separated his minor-league dominance from his 4.56 ERA across nine 2024 MLB starts.

Scott spoke plainly when the surgery was announced: "It sucks, obviously. I love to go out and compete. I love to do what I do. This is the best job in the world. So yeah, it sucks, but at the same time, this is what we sign up for."

For the Mets, success in Scott's next outings won't be measured in ERA. Pitch count extension, pushing past 75 or 80 pitches per appearance, matters more than runs allowed at this stage. So does walk rate: in his nine-start 2024 MLB stint, Scott held his walk rate at 6.1 percent, a manageable figure that held only when his 19.8 percent strikeout rate kept pace. Command against left-handed hitters, a noted vulnerability before the injury, will also be worth monitoring. His 2026 MLB timeline hinges on stacking quality innings, not surviving debuts.

The Mets' rotation is already crowded with Freddy Peralta, acquired from Milwaukee, alongside Kodai Senga, Clay Holmes, David Peterson, Sean Manaea, and Nolan McLean. Scott was always expected to open the year in Syracuse with a mid-season call-up as the target. One rough debut doesn't close that window, but it adds urgency to what the next month of starts needs to show.